Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : US3580291066
Share Class Description:
FMS: ADRCompare
Compare
Traded in other countries / regions
FMS.USAFME.Germany0H9X.UKFME.ItalyFME.AustriaFMSC34.BrazilFME.MexicoFME.Switzerland IPO Date
1996-09-17Description
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.93 | |||||
| Debt-to-EBITDA | 4.05 | |||||
| Interest Coverage | 2.84 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.5 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.6 | |||||
| 3-Year EBITDA Growth Rate | -3.5 | |||||
| 3-Year EPS without NRI Growth Rate | -16.6 | |||||
| 3-Year FCF Growth Rate | 1.1 | |||||
| 3-Year Book Growth Rate | 6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 16.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 2.96 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.53 | |||||
| 9-Day RSI | 56.52 | |||||
| 14-Day RSI | 58.17 | |||||
| 6-1 Month Momentum % | -25.86 | |||||
| 12-1 Month Momentum % | 6.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 59.84 | |||||
| Days Sales Outstanding | 71.26 | |||||
| Days Payable | 22.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 4.9 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 6.03 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.84 | |||||
| Operating Margin % | 6.03 | |||||
| Net Margin % | 2.31 | |||||
| FCF Margin % | 8.71 | |||||
| ROE % | 3.19 | |||||
| ROA % | 1.25 | |||||
| ROIC % | 2.42 | |||||
| ROC (Joel Greenblatt) % | 13.78 | |||||
| ROCE % | 4.67 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.19 | |||||
| Forward PE Ratio | 14.81 | |||||
| PE Ratio without NRI | 19.65 | |||||
| Shiller PE Ratio | 9.05 | |||||
| Price-to-Owner-Earnings | 6.32 | |||||
| PEG Ratio | 13.1 | |||||
| PS Ratio | 0.58 | |||||
| PB Ratio | 0.8 | |||||
| Price-to-Free-Cash-Flow | 6.71 | |||||
| Price-to-Operating-Cash-Flow | 4.49 | |||||
| EV-to-EBIT | 17.53 | |||||
| EV-to-Forward-EBIT | 12.21 | |||||
| EV-to-EBITDA | 7.56 | |||||
| EV-to-Forward-EBITDA | 6.74 | |||||
| EV-to-Revenue | 1.24 | |||||
| EV-to-Forward-Revenue | 1.09 | |||||
| EV-to-FCF | 13.2 | |||||
| Price-to-Projected-FCF | 0.41 | |||||
| Price-to-DCF (Earnings Based) | 1.45 | |||||
| Price-to-DCF (FCF Based) | 0.37 | |||||
| Price-to-Median-PS-Value | 0.43 | |||||
| Earnings Yield (Greenblatt) % | 5.7 | |||||
| FCF Yield % | 14.73 | |||||
| Forward Rate of Return (Yacktman) % | 14 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:FMS
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fresenius Medical Care AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20,825.805 | ||
| EPS (TTM) ($) | 0.819 | ||
| Beta | 1 | ||
| Volatility % | 46.56 | ||
| 14-Day RSI | 58.17 | ||
| 14-Day ATR ($) | 0.411943 | ||
| 20-Day SMA ($) | 19.629 | ||
| 12-1 Month Momentum % | 6.83 | ||
| 52-Week Range ($) | 15.35 - 27.715 | ||
| Shares Outstanding (Mil) | 586.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fresenius Medical Care AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fresenius Medical Care AG Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fresenius Medical Care AG Frequently Asked Questions
What is Fresenius Medical Care AG(FMS)'s stock price today?
The current price of FMS is $20.63. The 52 week high of FMS is $27.72 and 52 week low is $15.35.
When is next earnings date of Fresenius Medical Care AG(FMS)?
The next earnings date of Fresenius Medical Care AG(FMS) is 2024-02-22 Est..
Does Fresenius Medical Care AG(FMS) pay dividends? If so, how much?
Fresenius Medical Care AG(FMS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers